CabaƱog, Edna L.
HRN: 26-90-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/13/2025
04/19/2025
IV
4.5g
Q8h
T/c Sepsis, CAP HR
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes